CorMedix IncNASDAQ:CRMD
- LAST PRICE5.1900
- TODAY'S CHANGE (%)-0.1100 (-2.0755%)
- Bid / Lots5.1700/ 1
- Ask / Lots5.2800/ 10
- Open / Previous Close5.3300 / 5.3000
- Day Range
- 52 Week Range
- Volume440,516
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 8545 | 5.38 |
| 09:34 ET | 917 | 5.35 |
| 09:36 ET | 100 | 5.33 |
| 09:38 ET | 100 | 5.335 |
| 09:39 ET | 1100 | 5.335 |
| 09:41 ET | 926 | 5.33 |
| 09:43 ET | 720 | 5.335 |
| 09:45 ET | 100 | 5.325 |
| 09:48 ET | 1940 | 5.325 |
| 09:50 ET | 1300 | 5.335 |
| 09:52 ET | 2449 | 5.32 |
| 09:54 ET | 100 | 5.32 |
| 09:56 ET | 2450 | 5.315 |
| 09:57 ET | 200 | 5.305 |
| 09:59 ET | 5764 | 5.29 |
| 10:01 ET | 326 | 5.27 |
| 10:03 ET | 2637 | 5.2999 |
| 10:06 ET | 580 | 5.2899 |
| 10:08 ET | 100 | 5.285 |
| 10:10 ET | 1104 | 5.29 |
| 10:14 ET | 2590 | 5.2802 |
| 10:15 ET | 2052 | 5.285 |
| 10:17 ET | 300 | 5.27 |
| 10:19 ET | 2105 | 5.2697 |
| 10:21 ET | 1100 | 5.285 |
| 10:24 ET | 200 | 5.28 |
| 10:26 ET | 900 | 5.27 |
| 10:28 ET | 855 | 5.27 |
| 10:30 ET | 300 | 5.265 |
| 10:32 ET | 404 | 5.264 |
| 10:33 ET | 600 | 5.26 |
| 10:35 ET | 100 | 5.26 |
| 10:37 ET | 3000 | 5.28 |
| 10:39 ET | 100 | 5.2899 |
| 10:42 ET | 500 | 5.28 |
| 10:46 ET | 385 | 5.28 |
| 10:48 ET | 300 | 5.28 |
| 10:51 ET | 200 | 5.28 |
| 10:53 ET | 100 | 5.285 |
| 10:55 ET | 1500 | 5.28 |
| 10:57 ET | 200 | 5.28 |
| 11:02 ET | 100 | 5.28 |
| 11:04 ET | 134 | 5.2816 |
| 11:06 ET | 500 | 5.28 |
| 11:08 ET | 2092 | 5.2887 |
| 11:09 ET | 941 | 5.285 |
| 11:20 ET | 3700 | 5.31 |
| 11:22 ET | 100 | 5.31 |
| 11:26 ET | 541 | 5.3 |
| 11:27 ET | 300 | 5.3 |
| 11:29 ET | 1947 | 5.31 |
| 11:31 ET | 8463 | 5.31 |
| 11:33 ET | 700 | 5.305 |
| 11:36 ET | 500 | 5.305 |
| 11:38 ET | 743 | 5.305 |
| 11:40 ET | 164 | 5.3017 |
| 11:42 ET | 1300 | 5.295 |
| 11:45 ET | 16108 | 5.3009 |
| 11:47 ET | 6100 | 5.3 |
| 11:49 ET | 10747 | 5.295 |
| 11:51 ET | 222 | 5.295 |
| 11:54 ET | 2851 | 5.285 |
| 11:56 ET | 539 | 5.295 |
| 12:00 ET | 1040 | 5.28 |
| 12:02 ET | 122 | 5.285 |
| 12:03 ET | 100 | 5.28 |
| 12:05 ET | 5204 | 5.275 |
| 12:07 ET | 200 | 5.27 |
| 12:09 ET | 1100 | 5.275 |
| 12:12 ET | 2300 | 5.2711 |
| 12:14 ET | 36005 | 5.235 |
| 12:16 ET | 1094 | 5.215 |
| 12:18 ET | 1771 | 5.225 |
| 12:20 ET | 500 | 5.235 |
| 12:21 ET | 700 | 5.23 |
| 12:25 ET | 100 | 5.23 |
| 12:27 ET | 210 | 5.2343 |
| 12:30 ET | 544 | 5.235 |
| 12:32 ET | 100 | 5.23 |
| 12:36 ET | 100 | 5.23 |
| 12:38 ET | 1794 | 5.22 |
| 12:39 ET | 3556 | 5.215 |
| 12:41 ET | 2510 | 5.23 |
| 12:45 ET | 1521 | 5.24 |
| 12:48 ET | 500 | 5.25 |
| 12:50 ET | 675 | 5.25 |
| 12:52 ET | 300 | 5.255 |
| 12:54 ET | 200 | 5.25 |
| 12:57 ET | 860 | 5.24 |
| 12:59 ET | 200 | 5.25 |
| 01:01 ET | 2592 | 5.245 |
| 01:03 ET | 100 | 5.245 |
| 01:06 ET | 100 | 5.25 |
| 01:08 ET | 2053 | 5.235 |
| 01:10 ET | 243 | 5.225 |
| 01:12 ET | 1279 | 5.225 |
| 01:14 ET | 100 | 5.23 |
| 01:17 ET | 14751 | 5.2332 |
| 01:19 ET | 413 | 5.23 |
| 01:21 ET | 490 | 5.225 |
| 01:26 ET | 300 | 5.23 |
| 01:30 ET | 100 | 5.23 |
| 01:33 ET | 1100 | 5.235 |
| 01:35 ET | 355 | 5.225 |
| 01:37 ET | 400 | 5.23 |
| 01:39 ET | 545 | 5.24 |
| 01:42 ET | 1793 | 5.24 |
| 01:46 ET | 300 | 5.245 |
| 01:50 ET | 100 | 5.24 |
| 01:51 ET | 529 | 5.23 |
| 01:57 ET | 700 | 5.235 |
| 02:00 ET | 600 | 5.24 |
| 02:06 ET | 2203 | 5.23 |
| 02:08 ET | 2847 | 5.215 |
| 02:09 ET | 118 | 5.21 |
| 02:11 ET | 5670 | 5.2062 |
| 02:13 ET | 550 | 5.205 |
| 02:15 ET | 28381 | 5.195 |
| 02:18 ET | 1081 | 5.195 |
| 02:20 ET | 1579 | 5.215 |
| 02:27 ET | 601 | 5.21 |
| 02:29 ET | 600 | 5.205 |
| 02:31 ET | 200 | 5.205 |
| 02:33 ET | 200 | 5.205 |
| 02:36 ET | 2154 | 5.205 |
| 02:38 ET | 200 | 5.205 |
| 02:40 ET | 100 | 5.205 |
| 02:42 ET | 2691 | 5.21 |
| 02:44 ET | 1200 | 5.225 |
| 02:45 ET | 1915 | 5.225 |
| 02:49 ET | 200 | 5.22 |
| 02:51 ET | 100 | 5.22 |
| 02:54 ET | 3219 | 5.245 |
| 02:56 ET | 3929 | 5.235 |
| 03:00 ET | 400 | 5.235 |
| 03:02 ET | 100 | 5.2323 |
| 03:03 ET | 1109 | 5.235 |
| 03:12 ET | 227 | 5.235 |
| 03:14 ET | 200 | 5.23 |
| 03:16 ET | 200 | 5.23 |
| 03:18 ET | 4307 | 5.235 |
| 03:20 ET | 1006 | 5.21 |
| 03:21 ET | 1123 | 5.205 |
| 03:23 ET | 6288 | 5.19 |
| 03:25 ET | 200 | 5.19 |
| 03:27 ET | 300 | 5.195 |
| 03:30 ET | 6912 | 5.2159 |
| 03:32 ET | 100 | 5.215 |
| 03:34 ET | 4210 | 5.22 |
| 03:38 ET | 3507 | 5.2 |
| 03:39 ET | 200 | 5.195 |
| 03:41 ET | 400 | 5.195 |
| 03:43 ET | 2450 | 5.205 |
| 03:45 ET | 3094 | 5.2 |
| 03:48 ET | 600 | 5.204 |
| 03:50 ET | 300 | 5.205 |
| 03:52 ET | 4448 | 5.205 |
| 03:54 ET | 200 | 5.205 |
| 03:56 ET | 11294 | 5.2 |
| 03:57 ET | 1700 | 5.195 |
| 03:59 ET | 39313 | 5.19 |
Today
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath, from 14 hours ago by Dow Jones
14 hours ago by Dow Jones
May 28, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
8:30AM ET on Tuesday May 28, 2024 by Dow Jones
May 13, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:42AM ET on Monday May 13, 2024 by Dow Jones
5:42AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 289.8M | -5.6x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Zevra Therapeutics Inc | 194.6M | -3.5x | --- |
Calliditas Therapeutics AB | 1.2B | -22.3x | --- |
Assembly Biosciences Inc | 83.5M | -1.4x | --- |
Dbv Technologies SA | 119.3M | -0.7x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $289.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
